Short-term loop diuretic withdrawal in optimized heart failure with diabetes: A pilot randomized study integrating POCUS and NT-proBNP for congestion monitoring
Introduction: Loop diuretics (LD) are central in the management of heart failure (HF) congestion. However, prolonged use may contribute to poor outcomes and adverse events. Evidence supporting safe withdrawal of LD and appropriate patient selection among ambulatory HF patients with type 2 diabetes mellitus (T2DM) remains limited. We evaluated the safety of LD withdrawal, utilizing multiparametric congestion monitoring, and factors associated with congestion development in such patients. Methods: Sixty ambulatory HF patients with T2DM were randomized to either continuation or withdrawal of LD, in our open-label pilot study. Participants underwent assessment for congestion (subclinical and clinical) using a multiparametric approach, including lung ultrasound, venous excess ultrasound, N-terminal pro–B-type natriuretic peptide (NT-proBNP), and six-minute walk test. Results: In this study, 35.0% of participants developed congestion (31.7% subclinical and 15.0% clinical). There were no significant differences for subclinical (36.7% vs 26.7%; p=0.405), clinical (20.0% vs 10.0%; p=0.278), or composite congestion (43.4% vs 26.7%; p=0.176) between both study arms. Abnormal hepatic vein Doppler patterns (possibly suggestive of subclinical congestion) were more frequent in the LD withdrawal arm (16.7% vs 0.0%; p=0.020). Elevated baseline NT-proBNP was independently associated with subclinical (odds ratio [OR] 1.448; p=0.008), clinical (OR 1.737; p<0.001) and composite congestion (OR 1.480; p=0.015) in exploratory multivariable analyses. Conclusion: In this pilot open-label study, short-term loop diuretic withdrawal in carefully selected, clinically euvolemic ambulatory HF patients with T2DM, was feasible and not associated with a statistically significant excess of clinical or subclinical congestion over 4 weeks. These findings require confirmation in larger, adequately powered multicentre trials with longer follow-up and clinical outcomes.
Authors
- Norashikin Saidon
- Mohamad Rodi Isa (ORCID: https://orcid.org/0000-0002-8979-7794)
- Azrain Amri Mohd Farid
- Raja Ezman Raja Shariff
- Julina Md Noor
Institutions
- Universiti Teknologi MARA (MY)
Publication Details
- Journal
- The Ultrasound Journal
- Published
- 2026-11-20
- DOI
- https://doi.org/10.5826/tuj.2026.19594
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universiti Teknologi MARA